Variability in gene expression and tumor formation within genetically homogeneous animal populations in bioassays

Fundamental and Applied Toxicology

Volumn 29, Issue 2, 1996, Pages 176-184

  Wolff, George L ^a,b,c  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c NCTR   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPIC ACID DERIVATIVE; CARCINOGEN; DIMETHYLBENZ[A]ANTHRACENE; LINDANE; PHENOBARBITAL; PHENYLENEDIAMINE DERIVATIVE; ZEARALENONE; ZIRAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; BIOASSAY; CARCINOGENESIS; CARCINOGENICITY; FEMALE; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; RAT; REVIEW; TUMOR PROMOTION;

EID: 26844516176     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0019     Document Type: Review

References (30)

1. Bailey, D. W. (1978). Sources of subline divergence and their ralative importance for sublines of six major inbred strains of mice. In Origins of Inbred Mice (H. C. Morse III, Ed.), pp. 197-215, Academic Press, New York.
2. Bailey, D. W. (1982). How pure are inbred strains of mice? Immunol. Today 3, 210-214.
3. Cooper, D. M. F., Mons, N., and Karpen, J. W. (1995). Adenylyl cyclase and the interaction between calcium and cAMP signalling. Nature 374, 421-424.
4. Drinkwater, N. R. (1994). Genetic control of hepatocarcinogenesis in C3H mice. Drug. Metab. Rev. 26, 201-208.
5. Duhl, D. M. J., Vrieling, H., Miller, K. A., Wolff, G. L., and Barsh, G. S. (1994). Neomorphic agouti mutations in obese yellow mice. Nature Genet. 8, 59-65.
6. Festing, M. F. W. (1995). Use of a multistrain assay could improve the NTP carcinogenesis bioassay. Environ. Health Perspect. 103, 44-52.
7. Gärtner, K. (1990). A third component causing random variability beside environment and genotype: A reason for the limited success of a 30 year long effort to standardize laboratory animas? Lab. Anim. 24, 71-77.
8. Haseman, J. K. (1985). Issues in carcinogenicity testing: Dose selection. Fundam. Appl. Toxicol. 5, 66-78.
9. Haseman, J. K., Huff, J. E., Rao, G. N., and Eustis, S. L. (1989). Sources of variability in rodent carcinogenicity studies Fundam. Appl. Toxicol. 12, 793-804.
10. Hershman, H. R. (1991). Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem. 60, 281-319.
11. vy) of the mouse agouti locus Mol. Carcinogen. 15, 70-80.
12. Kwon, H. Y., Bultman, S. J., Löffler, C., Chen, W-J., Furdon, P. J., Powell, J. G., Usala, A-L., Wilkison, W., Hansmann, I., and Woychik, R. P. (1994). Molecular structure and chromosomal mapping of the human homolog of the agouti gene. Proc. Natl. Acad. Sci. USA 91, 9760-9764.
13. Lu, D., Willard, D., Patel, I. R., Kadwell, S., Overton, L., Kost, T., Luther, M., Chen, W., Woychik, R. P., and Cone, R. D. (1994). Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371, 799-802.
14. lapy) is correlated with methylation state and is influenced by parental lineage. Genes Dev. 8, 1463-1472.
15. Mintz, B., and Bradl, M. (1991). Mosaic expression of a tyrosinase fusion gene in albino mice yields a heritable striped coat color pattern in transgenic homozygotes. Proc. Natl. Acad. Sci. USA 88, 9643-9647.
16. Mountjoy, K. G., Mortrud, M. T., Low, M. J., Simerly, R. B., and Cone, R. D. (1994). Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8, 1298-1308.
17. Papavassiliou, A. G. (1995). Transcription factors N. Engl. J. Med. 332, 45-47.
18. Papavassiliou, A. G. (1994). The CREB/ATF family of transcription factors: Modulation by reversible phosphorylation. Anticancer Res. 14, 1801-1806.
19. Vallejo, M. (1994). Transcriptional control of gene expression by cAMP-response dement binding proteins. J. Neuroendocrinol. 6, 587-596.
20. Wilson, B. D., Ollmann, M. M., Kang, L., Stoffel, M., Bell, G. I., and Barsh, G. S (1995). Structure and function of ASP, the human homolog of the mouse agouti gene. Hum. Mol. Genet. 4, 223-230.
21. Wolff, G. L. (1961). Some genetic aspects of physiological variability. Cancer Res. 21, 1119-1123.
22. Wolff, G. L. (1978). Influence of maternal phenotype on metabolic differentiation of agouti locus mutants in the mouse. Genetics 88, 529-539.
23. 1 hybrid mice. J. Toxicol. Environ. Health 10, 131-142.
24. vy/ A (C3H × VY) F-1 hybrid mice, Carcinogenesis 7, 1895-1898.
25. Wolff, G. L., Morrissey, R. L., and Chen, J. J. (1986b). Susceptible and resistant subgroups in genetically identical populations: Response of mouse liver neoplasia and body weight to phenobarbital. Carcinogenesis 7, 1935-1937.
26. Wolff, G. L., Roberts, D. W., Morrissey, R. L., Greenman, D. L., Allen, R. R., Campbell, W. L., Bergman, H., Nesnow, S., and Frith, C. H. (1987). Tumorigenic responses to lindane in mice: Potentiation by a dominant mutation. Carcinogenesis 8, 1889-1897.
27. 1 hybrid mice. Carcinogenesis 12, 911-915.
28. Wright, S. (1949). Differentiation of strains of guinea pigs under inbreeding. Proc. Natl. Cancer Conf. 1, 13-27.
29. vy/- mice: Ectopic expression of the agouti gene. FASEB J. 8, 479-488.
30. Zemel, M. B., Kim, J. H., Woychik, R. P., Michaud, E. J., Kadwell, S. H., Patel, I. R., and Wilkison, W. O. (1995). Agouti regulation of intracellular calcium: Role in the insulin resistance of viable yellow mice. Proc. Natl. Acad. Sci. USA 92, 4733-4737.